Healthcare provider profile · identity verified

Matthew Huddleston, MD

Family Practice · MIDDLETOWN, CT · NPI 1063418218

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	360	88
Amlodipine Besylate	Amlodipine Besylate	353	96
Gabapentin	Gabapentin	345	47
Rosuvastatin Calcium	Rosuvastatin Calcium	283	69
Pantoprazole Sodium	Pantoprazole Sodium	262	55
Lisinopril	Lisinopril	258	73
Ozempic	Semaglutide	241	37
Albuterol Sulfate Hfa	Albuterol Sulfate	239	56
Levothyroxine Sodium	Levothyroxine Sodium	215	50
Jardiance	Empagliflozin	173	37
Famotidine	Famotidine	165	33
Diclofenac Sodium	Diclofenac Sodium	161	40
Metformin Hcl	Metformin Hcl	152	38
Fluticasone Propionate	Fluticasone Propionate	134	48
Omeprazole	Omeprazole	133	31
Losartan Potassium	Losartan Potassium	121	31
Metformin Hcl Er	Metformin Hcl	120	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	120	16
Oxycodone Hcl	Oxycodone Hcl	116	13
Metoprolol Succinate	Metoprolol Succinate	115	30
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	111	12
Hydrochlorothiazide	Hydrochlorothiazide	108	40
Pravastatin Sodium	Pravastatin Sodium	99	26
Furosemide	Furosemide	94	21
Montelukast Sodium	Montelukast Sodium	85	18
Tamsulosin Hcl	Tamsulosin Hcl	79	24
Pregabalin	Pregabalin	74	14
Ventolin Hfa	Albuterol Sulfate	74	13
Morphine Sulfate Er	Morphine Sulfate	72	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	68	suppressed
Ketoconazole	Ketoconazole	66	29
Trazodone Hcl	Trazodone Hcl	66	12
Varenicline Tartrate	Varenicline Tartrate	63	15
Duloxetine Hcl	Duloxetine Hcl	61	13
Ibuprofen	Ibuprofen	61	18
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	58	14
Hydroxyzine Hcl	Hydroxyzine Hcl	58	suppressed
Tramadol Hcl	Tramadol Hcl	58	11
Buprenorphine Hcl	Buprenorphine Hcl	57	suppressed
Meloxicam	Meloxicam	55	12
Escitalopram Oxalate	Escitalopram Oxalate	54	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	50	15
Eliquis	Apixaban	50	13
Hydrocortisone	Hydrocortisone	50	15
Clonazepam	Clonazepam	49	suppressed
Carvedilol	Carvedilol	47	12
Spironolactone	Spironolactone	47	14
Trulicity	Dulaglutide	47	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	45	11
Mirtazapine	Mirtazapine	45	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Bupropion Xl	Bupropion Hcl	42	suppressed
Mounjaro	Tirzepatide	42	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Buspirone Hcl	Buspirone Hcl	40	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	40	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	16
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Oxycontin	Oxycodone Hcl	38	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	12
Simvastatin	Simvastatin	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Alprazolam	Alprazolam	34	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Clotrimazole	Clotrimazole	33	17
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Baclofen	Baclofen	29	suppressed
Loperamide	Loperamide Hcl	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Divalproex Sodium Er	Divalproex Sodium	28	suppressed
Ondansetron Odt	Ondansetron	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Topiramate	Topiramate	28	suppressed
Tivicay	Dolutegravir Sodium	27	suppressed
Olanzapine	Olanzapine	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Juluca	Dolutegravir/Rilpivirine	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	25	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	24	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Dovato	Dolutegravir Sodium/Lamivudine	22	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	21	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	19	suppressed
Diazepam	Diazepam	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Linzess	Linaclotide	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	19	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	18	suppressed
Fluconazole	Fluconazole	18	11
Lamotrigine	Lamotrigine	18	suppressed
Prazosin Hcl	Prazosin Hcl	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	16	suppressed
Desloratadine	Desloratadine	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Naproxen	Naproxen	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Easy Comfort Pen Needles	Pen Needle, Diabetic	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Exemestane	Exemestane	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Movantik	Naloxegol Oxalate	13	suppressed
Prednisone	Prednisone	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Atenolol	Atenolol	12	suppressed
Colchicine	Colchicine	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Donepezil Hcl Odt	Donepezil Hcl	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Clonidine	Clonidine	11	suppressed
Lactulose	Lactulose	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Restasis	Cyclosporine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error